Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

N-nitrosoephedrine and N-nitrosopseudoephedrine: their dissolution, absorption, blood clearance and elimination studies.

Al-Hindawi MK, Alwan SM, Abdul-Rahman SK, Ismail MA, Al-Sarraj S.

Cancer Lett. 1988 Jan;38(3):329-37.

PMID:
3349451
2.

Production of nitrosamines from ephedrine, pseudoephedrine and extracts of Ephedra foliata under physiological conditions.

Alwan SM, Al-Hindawi MK, Abdul-Rahman SK, Al-Sarraj S.

Cancer Lett. 1986 May;31(2):221-6.

PMID:
3697965
3.

Nitrosation products from the plant Ephedra altissima and their potential endogenous formation.

Tricker AR, Wacker CD, Preussmann R.

Cancer Lett. 1987 May;35(2):199-206.

PMID:
3581050
5.

Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates.

Kortejärvi H, Urtti A, Yliperttula M.

Eur J Pharm Sci. 2007 Feb;30(2):155-66. Epub 2006 Nov 11.

PMID:
17187967
6.

The effect of solubility on inhaled uranium compound clearance: a review.

Eidson AF.

Health Phys. 1994 Jul;67(1):1-14. Review.

PMID:
8200796
8.

Effect of Five Alive fruit juice on the dissolution and absorption profiles of ciprofloxacin.

Akinleye MO, Coker HA, Chukwuani CM, Adeoye AW.

Nig Q J Hosp Med. 2007 Jan-Mar;17(1):53-7.

PMID:
17688173
9.

Dissolution rate and in situ intestinal absorption kinetics of guanyl-cysteine.

Barcia E, Molina IT, Cadorniga R.

Boll Chim Farm. 1989 Oct;128(10):303-9.

PMID:
2635915
10.

Toxicokinetics of inhaled 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in F344 rats and B6C3F1 mice.

Dill JA, Lee KM, Bates DJ, Anderson DJ, Johnson RE, Chou BJ, Burka LT, Roycroft JH.

Toxicol Appl Pharmacol. 1998 Dec;153(2):227-42.

PMID:
9878593
11.

Rate-limiting steps of oral absorption for poorly water-soluble drugs in dogs; prediction from a miniscale dissolution test and a physiologically-based computer simulation.

Takano R, Furumoto K, Shiraki K, Takata N, Hayashi Y, Aso Y, Yamashita S.

Pharm Res. 2008 Oct;25(10):2334-44. doi: 10.1007/s11095-008-9637-9. Epub 2008 Jun 17.

PMID:
18560998
12.
13.

A comparative review of the pharmacokinetics of boric acid in rodents and humans.

Murray FJ.

Biol Trace Elem Res. 1998 Winter;66(1-3):331-41. Review.

PMID:
10050928
14.

Gender differences in the metabolism and pharmacokinetics of the experimental anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).

Zhou S, Kestell P, Tingle MD, Paxton JW.

Cancer Chemother Pharmacol. 2002 Feb;49(2):126-32. Epub 2001 Oct 24.

PMID:
11862426
15.

Prediction of oral absorption of griseofulvin, a BCS class II drug, based on GITA model: utilization of a more suitable medium for in-vitro dissolution study.

Fujioka Y, Kadono K, Fujie Y, Metsugi Y, Ogawara K, Higaki K, Kimura T.

J Control Release. 2007 Jun 4;119(2):222-8. Epub 2007 Mar 13.

PMID:
17442444
17.
18.

Effect of bicycle exercise on insulin absorption and subcutaneous blood flow in the normal subject.

Ferrannini E, Linde B, Faber O.

Clin Physiol. 1982 Feb;2(1):59-70.

PMID:
7049512
19.
20.

Dissolution rate-limited absorption and complete bioavailability of roquinimex in man.

Strandgârden K, Höglund P, Nordle O, Polacek J, Wännman H, Gunnarsson PO.

Biopharm Drug Dispos. 1999 Oct;20(7):347-54.

PMID:
10760843

Supplemental Content

Support Center